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This paper is the first report from the Percutaneous Trans-
luminal Coronary Angioplasty (PTCA) Registry of the
National Heart, Lung, and Blood Institute (NHLBI). The
era of interventional cardiology was born with the perfor-
mance of the first successful balloon angioplasty by Andreas
Gruentzig on September 16, 1977 (1). The background for
this extraordinary accomplishment required the develop-
ment of coronary arteriography, direct coronary bypass
surgery and percutaneous peripheral vascular dilation. Gru-
entzig’s willingness to teach the technique in its earliest
rudimentary form to all who would come to Zurich was
aided by the first set of disciples, including Myler, Stertzer,
Kaltenbach and others. By 1979, a small number of cases
had been accumulated, and the companies manufacturing
the devices continued to control the proliferation of the
technique by releasing catheters only to those physicians
who had visited and observed Gruentzig at work. As more
operators began to perform angioplasty in the U.S., it
became evident that a more organized evaluation of this
fledgling technology could be of great value. After a con-
versation with Gruentzig and others, Dr. Michael Mook of
the NHLBI was instrumental in convening a workshop in
June 1979 at the Institute headquarters in Bethesda, Mary-
land. The outcome of that workshop was the formation of
an international registry of PTCA patients that would
provide a meaningful evaluation of this new procedure (2).
An initial report from the accumulated experience was
presented at that workshop, and virtually all of the early
practitioners of angioplasty joined that registry.
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ABSTRACT
Data have been collected from 34 centers in the United States
and Europe performing percutaneous transluminal coronary
angioplasty since September 1977. The procedure was carried
out in 631 patients, with an average age of 51 years (range 23
to 76), of whom 80 percent had single vessel coronary disease, 17
percent had double or triple vessel disease and 3 percent had
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INTRODUCTION
In this edition of the Journal, we release the tenth in a series of
reviews of influential articles that have been previously pub-
lished in ACC journals, including the American Journal of Cardi-
ology (from 1958 to 1982) and JACC (from 1983 to the present).
The publication of these articles is only one aspect of the ACC’s
50th anniversary commemoration, which highlights 50 years of
leadership in cardiovascular care and education. The articles are
intended to encourage reflection on the remarkable progress made
in cardiovascular medicine over time, as well as to acknowledge the
amazing prescience of some early investigators in anticipating and,
in many cases, later guiding developments in their field.
The working group responsible for selecting these articles and
asking reviewers to write editorials solicited suggestions from
the ACC’s clinical committees and individual members.
The group achieved consensus fairly easily, including whom the
group should ask to prepare the accompanying editorials. We
initially drew up a list of 14 general areas to cover in this series,
but later found that there are several major areas of modern
cardiology, prominently molecular cardiology, in which the truly
landmark articles have, alas, not yet been published in JACC.
Therefore, the working group decided not to categorize by subject,
but instead, to concentrate on the most important articles.
The working group, a task force of the Subcommittee for the
Commemoration of the ACC 50th Anniversary, owes a great
deal to Ms. May A. Roustom and the efficient and tireless staff
at Heart House for facilitating this project. We also wish to
thank all who suggested articles and, most important, the
authors who prepared reviews for their willingness to contribute
their time and wisdom.
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stenosis of the left main coronary artery. Coronary angioplasty was
successful (greater than 20 percent decrease of coronary stenosis) in
59 percent of the stenosed arteries. The mean degree of stenosis was
reduced from 83 to 31 percent. Emergency coronary bypass opera-
tion was required in 40 patients (6 percent). Myocardial infarction
occurred in 29 patients (4 percent). In-hospital death occurred in six
patients (1 percent), three with single vessel and three with
multivessel disease. Ninety-one patients have been followed up for
at least 1 year after coronary angioplasty. Of the 65 patients with
an initially successful angioplasty, 83 percent were in improved
condition compared with their status before angioplasty. Thus, the
initial satisfactory results obtained in a few centers have now been
confirmed in many centers using transluminal coronary angio-
plasty.
Originally published in the Journal of the American College of Cardiology, June
1982.
Review
This first report from 34 centers in the U.S. and Europe had
traced their entire experience with angioplasty. The kind of
patients treated reflected Gruentzig’s initial recommenda-
tions in that 80% had single-vessel disease. With the
primitive equipment available, 59% had successful dilation.
The complication rates, including emergency operations,
myocardial infarction and death, reflected a careful selection
of patients, and the first one-year follow-up documented
symptomatic improvement.
The NHLBI PTCA Registry was pivotal in the devel-
opment of interventional cardiology, as it showed for the
first time that Gruentzig’s experimental procedure could be
applied to a broader range of patients by multiple operators.
The spirit of collegiality and cooperative assessment of the
technique in its early days was perhaps unique. Many of the
original investigators of balloon angioplasty have continued
to cooperate with the registry, which was moved to the
School of Public Health at the University of Pittsburgh
under the organizational structure of Dr. Katherine Detre.
A subsequent registry was instituted after balloon angio-
plasty had achieved a more mature status. Patient data were
collected in 1985 and 1986 by the NHLBI Registry partic-
ipants, and these data have been compared with the earlier
period (3). Improvements were documented after important
technologic advances, including, especially, the develop-
ment in 1982 of steerable guide wires.
The value of prospectively collected registry data has
perhaps been underappreciated in this era of large targeted
randomized trials, but these data were essential for under-
standing the baseline features of patients undergoing angio-
plasty and their outcomes. This registry, in fact, set the stage
for development of randomized trials. Much of the planning
and structure of the Emory Angioplasty versus Surgery Trial
(4) and the Bypass Angioplasty Revascularization Investi-
gation (5), both sponsored by the NHLBI, were based on
data generated from the NHLBI PTCA Registries. As new
devices began to be developed in the late 1980s, another
registry, the New Approaches to Coronary Interventions
(NACI) Registry, was developed. It has been possible to
compare the use and outcome of many of these new devices
with the NHLBI Registries and to structure clinical trials to
investigate those devices (6). More recently, the registry has
evolved into the Dynamic Registry of Percutaneous Coronary
Interventions. During defined collection periods, the partici-
pating NHLBI sites enter all patients into a defined database.
By doing so, a snapshot of interventional cardiology practice
can be generated to reflect changes in practice patterns and
outcomes. The last two registry collection periods in 1997/
1998 and in 1999 show continuing evolution of the method
with increased utilization of stenting with concombinant im-
provement in acute complication rates. These registries will
also enable assessment of long-term outcomes based on meth-
odologic changes and in subgroups of great interest including
gender, racial and ethnic differences and disease state differ-
ences, especially for the diabetic population. In addition to
identifying current practice results, the registries will stimulate
questions that need further randomized trials. In fact, many of
the ongoing trials, including stent trials (Stent or Surgery,
ARTS trial) and angioplasty versus medical treatment trials
(Veterans Affairs Non-Q-Wave Infarction Strategies in Hos-
pital study [VANQWISH], Coronary angioplasty versus med-
ical therapy for angina [RITA-2], Fragmin during Instability
in Coronary artery disease [FRISC II], planned Bypass An-
gioplasty Revascularization Investigation [BARI II], Clinical
Outcomes Utilizing Revascularization and Aggressive Drug
Evaluation [COURAGE], and Study of Coronary Revascu-
larization And Therapeutics Evaluations [SOCRATES]), all
gained valuable data from understanding the registry results.
These registries also have the potential to serve an important
postmarketing surveillance function. Currently, new devices
must undergo some comparative evaluation before approval by
the Food and Drug Administration (FDA), but these evalua-
tions are made on the basis of a carefully defined population of
patients. The real-world use of devices cannot be adequately
assessed by either the FDA or the device manufacturers
because once the device is approved, its utilization is broadened
by practitioners. The registry has the potential to collect
unselected data that will include the utilization of these new
devices and may detect problematic indications or provide data
that can enable broader labeling of these devices. It is impor-
tant to understand what new devices are doing in actual
practice in addition to what they did in a controlled preclinical
evaluation.
The NHLBI PTCA Registries have resulted in 45
peer-reviewed articles in the medical literature, including
the long-term efficacy of PTCA (7), the comparison of
changes in interventional technology (3), the incidence and
consequence of occlusion of coronary arteries (8), the
outcome of coronary angioplasty in women (9), the cause of
death in late-term follow-up of patients undergoing angio-
plasty (10) and the comparison of balloon angioplasty with
new late-developing technologies (6). According to the
616 King JACC Vol. 34, No. 3, 1999
Percutaneous Transluminal Coronary Angioplasty September 1999:615–7
Science Citation Index, publications from the NHLBI
Registries were cited a total of 3,757 times by February
1996. Obviously, these registries have been important in the
development of interventional cardiology, and the use of
such registries has been adopted by others in an attempt to
evaluate the outcome of procedures and disease states.
Important examples are the New York State Registry (11)
and the National Cardiovascular Data Registry™ of the
American College of Cardiology.
CONCLUSION
The forward-thinking pioneers of interventional cardiology
and the leadership of the NHLBI and the Data Center at
the University of Pittsburgh are to be congratulated for both
their foresight and persistence. The founding of the initial
registry formed the basis of this communication, and the
continuity of registry activity through the years has enabled
an assessment of the dynamic nature of interventional
cardiology. Twenty-two years since the first coronary an-
gioplasty by Andreas Gruentzig, these techniques have
evolved into an entire subspecialty discipline now recog-
nized by its own board or certificate of added qualification
from the American Board of Internal Medicine and have
defined residency programs approved by the Accrediting
Council on Graduate Medical Education. This first report
of outcomes of the NHLBI PTCA Registry established the
tradition of collaborative openness in assessing results that
Gruentzig espoused so vigorously. This objective, unbiased
assessment of ongoing outcomes in interventional cardiol-
ogy will remain an important part of his legacy.
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